Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves. [Review] 

 -  2022 
<br/><br/> Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves. Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>1936-8798 
<br/><br/><label>Standard No.: </label>10.1016/j.jcin.2022.07.035 [doi] S1936-8798(22)01483-2 [pii] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Aortic Valve Stenosis<br/>*Bioprosthesis<br/>*Heart Valve Prosthesis<br/>*Heart Valve Prosthesis Implantation<br/>*Transcatheter Aortic Valve Replacement<br/>Aortic Valve Stenosis/dg [Diagnostic Imaging]<br/>Aortic Valve Stenosis/et [Etiology]<br/>Aortic Valve Stenosis/su [Surgery]<br/>Aortic Valve/dg [Diagnostic Imaging]<br/>Aortic Valve/su [Surgery]<br/>Heart Valve Prosthesis Implantation/ae [Adverse Effects]<br/>Heart Valve Prosthesis Implantation/mt [Methods]<br/>Humans<br/>Prosthesis Design<br/>Prosthesis Failure<br/>Transcatheter Aortic Valve Replacement/ae [Adverse Effects]<br/>Transcatheter Aortic Valve Replacement/mt [Methods]<br/>Treatment Outcome
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Heart & Vascular Institute
<br/><br/><label>Index Terms--Function: </label><br/>Journal Article<br/>Review